Mostrar el registro sencillo del ítem

dc.contributor.advisorDe-la-Cruz-Cortés, José Pedro 
dc.contributor.advisorGonzález-Correa, José Antonio 
dc.contributor.advisorReyes de la Vega, José Julio
dc.contributor.authorVillanueva Torres, Beatriz
dc.date.accessioned2017-07-25T10:05:28Z
dc.date.available2017-07-25T10:05:28Z
dc.date.issued2016
dc.identifier.urihttp://hdl.handle.net/10630/14349
dc.description.abstractThe aim of this study is to assess whether the administration of hydroxytyrosol (HT) to diabetic animals exerts a neuroprotective effect on brain damage in a model of hypoxia-reoxygenation. Rats (10 per group) were distributed in five groups: nondiabetic rats, control diabetic rats (DR), DR rats treated two months with 1, 5 or 10 mg/kg/day p.o. HT. At the end of follow-up an experimental model of hypoxia-reoxygenation in brain slices was carried out. DR showed increased cell death, oxidative and nitrosative stress and an increase in brain inflammatory mediators. All these alterations were significantly higher in DR than normoglycemic. HT significantly reduced oxidative and nitrosative stress and brain inflammatory mediators production. Cell death was reduced by 25.9%, 37.5% and 41.0% after the administration of 1, 5 or 10 mg/kg/day. In conclusion we provide the neuroprotective effect of the administration of HT in experimental diabetes.es_ES
dc.language.isospaes_ES
dc.publisherUMA Editoriales_ES
dc.rightsby-nc-nd
dc.subjectPolifenoleses_ES
dc.subject.otherTesis doctorales_ES
dc.subject.otherDiabetes experimentales_ES
dc.subject.otherHidroxitirosoles_ES
dc.subject.otherneuroprotecciónes_ES
dc.titleDiferencias en el efecto antioxidante y neuroprotector de hidroxitirosol en la diabetes mellitus experimental respecto a una situación de normoglucemiaes_ES
dc.typedoctoral thesises_ES
dc.centroFacultad de Medicinaes_ES
dc.departamentoFarmacología y Pediatría
dc.rights.accessRightsopen accesses_ES


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem